全基因组测序用于胎儿结构异常的产前评估:一项前瞻性多中心研究
该前瞻性多中心研究对96例胎儿结构异常的核心家系(父母-胎儿三人组)平行进行全基因组测序与拷贝数变异测序加外显子测序,比较两种策略的产前诊断效能。全基因组测序在联合方案基础上额外检出3例,将诊断率从30/96(31.2%)提升至33/96(34.4%),并检出仅由全基因组测序发现的结构变异等偶发发现。
要点
- 拷贝数变异测序加三人组外显子测序的联合诊断率为30/96(31.2%)。
- 三人组全基因组测序将诊断率提高至33/96(34.4%),额外检出3例。
- 全基因组测序可检出联合方案未发现的结构变异等偶发发现。
核心结论
- 三人组全基因组测序可作为拷贝数变异测序加外显子测序的有效替代方案,能对胎儿结构异常进行更全面的基因组分析,并可将实验室流程整合为单一检测。
研究设计与样本
- 前瞻性多中心研究,对96例胎儿结构异常的核心家系(父母-胎儿三人组)平行进行全基因组测序与拷贝数变异测序加外显子测序。
- 单核苷酸变异、小插入/缺失、拷贝数变异、结构变异和杂合性缺失按照美国医学遗传学与基因组学学会、分子病理学协会和ClinGen指南进行分类。
主要发现
- 拷贝数变异测序检出诊断性变异5/96(5.2%)例胎儿,三人组外显子测序检出26/96(27.1%)例胎儿。
- 拷贝数变异测序加三人组外显子测序的联合诊断率为30/96(31.2%)。
- 全基因组测序检出拷贝数变异测序和三人组外显子测序的全部诊断性变异,并额外检出3例胎儿(1例母源性15号染色体单亲二体、1例复杂染色体结构重排、1例NADSYN1基因复合杂合单核苷酸变异),将诊断率提高至33/96(34.4%)。
- 诊断率最高的胎儿表型为颅面部异常(2/3,66.7%),其次为水肿(3/6,50.0%)。
- 检出偶发发现10个家系(10.5%,10/96),其中7例胎儿的结构变异仅由全基因组测序检出,包括6例倒位和1例16号染色体单亲二体。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The clinical validity of whole-genome sequencing in postnatal settings is well documented, but studies of its use in prenatal settings are limited. OBJECTIVE: The objective of this study was to prospectively evaluate the performance of whole-genome sequencing for prenatal diagnosis of fetal structural anomalies compared with the commonly used testing strategy of copy-number variant sequencing plus exome sequencing. STUDY DESIGN: Whole-genome sequencing was performed in parallel with copy-number variant sequencing and exome sequencing for 96 parent-fetus trios with fetal structural anomalies. Single-nucleotide variants, small insertions/deletions, copy-number variations, structural variants, and absence of heterozygosity were classified according to the American College of Medical Genetics and Genomics, Association for Molecular Pathology, and ClinGen guidelines. RESULTS: Diagnostic variants were found by copy-number variant sequencing for 5/96 (5.2%) fetuses and by trio-exome sequencing for 26/96 (27.1%) fetuses. The combined diagnostic rate for copy-number variant sequencing plus trio-exome sequencing was 30/96 (31.2%). Whole-genome sequencing identified all diagnostic variants detected by copy-number variant sequencing and trio-exome sequencing plus 3 additional fetuses (one with maternal uniparental disomy 15, one with a complex chromosomal rearrangement, and one with compound heterozygous single-nucleotide variants in NADSYN1), increasing the diagnostic rate to 33/96 (34.4%). The highest diagnostic rate was observed in fetuses with craniofacial abnormalities (2/3, 66.7%), followed by those with hydrops (3/6, 50.0%). Ten families (10.5%, 10/96) were detected with incidental findings, of which, structural variants in 7 fetuses were detected only by whole-genome sequencing, including 6 inversions and one uniparental disomy 16. CONCLUSION: Trio-based whole-genome sequencing offers a valid alternative to copy-number variant sequencing plus exome sequencing, demonstrating the capacity for more comprehensive genomic analysis for fetuses with structural anomalies while permitting consolidation of laboratory workflows into a single test.
引用
- Gao Z, Liu M, Jiang J, et al. Whole-genome sequencing for the prenatal evaluation of fetal structural anomalies: a prospective multicenter study. Am J Obstet Gynecol. 2025. PMID: 40865752. doi:10.1016/j.ajog.2025.08.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。